Salvage holmium laser enucleation of the prostate after previous interventions: a systematic review.
BPH
HoLEP
holmium laser
outcomes
prostate
re-treatment
recurrent
residual
salvage
Journal
BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721
Informations de publication
Date de publication:
17 Jul 2023
17 Jul 2023
Historique:
pubmed:
18
7
2023
medline:
18
7
2023
entrez:
18
7
2023
Statut:
aheadofprint
Résumé
To investigate the feasibility, safety and efficacy of holmium laser enucleation of the prostate (HoLEP) in the re-treatment setting (salvage HoLEP) and compare it to the primary HoLEP procedure that is commonly used for the treatment of benign prostate hyperplasia (BPH). Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, PubMed, Scopus, and Cochrane databases were systematically screened, from inception to 8 August 2022. Other potentially eligible studies were retrieved using the reference lists of the included studies. Retrospective and prospective studies, both comparative and non-comparative, were included. A total of 12 studies met the inclusion criteria and were included in the final qualitative synthesis. One study was prospective comparative (non-randomised), seven studies were retrospective comparative, and four studies were retrospective non-comparative or case series. In total, 831 patients were treated with salvage HoLEP in the above studies. Previous intervention before salvage HoLEP ranged among studies. The most commonly performed was transurethral resection of the prostate. Intraoperative parameters of salvage HoLEP were comparable with those reported during primary HoLEP, while all postoperative outcomes were significantly improved after salvage HoLEP and were similar with those observed after primary HoLEP. No major complications were noted after salvage HoLEP according to Clavien-Dindo classification. Salvage HoLEP after previous interventions for treating recurrent or residual BPH is a feasible, safe, and efficient procedure. Data presented in selected studies, along with the holmium laser's physical properties to resect more tissue and to dissect along the true anatomical plane of BPH, render HoLEP an ideal salvage treatment modality for recurrent or residual BPH symptoms.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 BJU International.
Références
Yu J, Jeong BC, Jeon SS, Lee SW, Lee KS. Comparison of efficacy of different surgical techniques for benign prostatic obstruction. Int Neurourol J 2021; 25: 252-262
Shvero A, Calio B, Humphreys MR, Das AK. HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia. Can J Urol 2021; 28(S2): 6-10
Fraundorfer MR, Gilling PJ. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 1998; 33: 69-72
Parmar M, Katz JE, Blachman-Braun R et al. Safety and efficacy of holmium laser enucleation of prostate as salvage procedure for persistent or recurrent lower urinary tract symptoms secondary to bladder outlet obstruction after prior prostate artery embolization: a match analysis. World J Urol 2021; 39: 4199-4206
Marien T, Kadihasanoglu M, Tangpaitoon T et al. Outcomes of holmium laser enucleation of the prostate in the re-treatment setting. J Urol 2017; 197: 1517-1522
Oh JK, Bae J, Jeong CW, Paick JS, Oh SJ. Salvage holmium laser enucleation of prostate to treat residual benign prostatic hyperplasia. Can Urol Assoc J 2014; 8: E235-E240
Elshal AM, Elmansy HM, Elhilali MM. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH). BJU Int 2012; 110(11 Pt C): E845-E850
Khater U, Smith NA, Katz JE et al. Does prior transurethral resection of prostate have a negative impact on the outcome of holmium laser enucleation of prostate? Results from a prospective comparative study. Urol Ann 2022; 14: 118-124
Becker B, Netsch C, Glybochko P, Rapoport L, Taratkin M, Enikeev D. A feasibility study utilizing the thulium and holmium laser in patients for the treatment of recurrent benign prostatic hyperplasia after previous prostatic surgery. Urol Int 2018; 101: 212-218
Jaeger CD, Krambeck AE. Holmium laser enucleation of the prostate for persistent lower urinary tract symptoms after prior benign prostatic hyperplasia surgery. Urology 2013; 81: 1025-1029
Durant AM, Moore J, Voleti S et al. Salvage versus primary holmium laser enucleation of the prostate: trends, outcomes and safety analysis. World J Urol 2022; 40: 2305-2312
Li P, Wang C, Cao Q, Zhang J, Shi H, Meng X. Prostatic arterial embolization followed by holmium laser enucleation of the prostate as a planned combined approach for extremely enlarged benign prostate hyperplasia. Urol Int 2017; 99: 422-428
McAdams S, Funk JT, Navetta AF, El Tayeb MM, Humphreys MR. Holmium laser enucleation of the prostate after prostatic urethral lift surgery: feasibility and technical considerations from a multi-institutional case series. J Endourol 2017; 31: 774-779
Parikh KA, Dora CD. Holmium laser enucleation of the prostate after failed UroLift: surgical considerations for the management of nonabsorbable implants. Urology 2019; 132: 212
Banerjee I, Smith NA, Katz JE, Gokhale A, Shah R, Shah HN. Simultaneous holmium laser enucleation of prostate with removal of the permanent prostatic urethral stent using the high-power holmium laser: technique in two cases and review of the literature. J Endourol Case Rep 2020; 6: 438-441
Jensen KM, Jørgensen TB, Mogensen P. Long-term predictive role of urodynamics: an 8-year follow-up of prostatic surgery for lower urinary tract symptoms. Br J Urol 1996; 78: 213-218
Roos NP, Wennberg JE, Malenka DJ et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989; 320: 1120-1124
Ray AF, Powell J, Speakman MJ et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int 2018; 122: 270-282
Costa NV, Torres D, Pisco J et al. Repeat prostatic artery embolization for patients with benign prostatic hyperplasia. J Vasc Interv Radiol 2020; 31: 1272-1280
Perera M, Roberts MJ, Doi SA, Bolton D. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol 2015; 67: 704-713
Roehrborn CG, Rukstalis DB, Barkin J et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 2015; 22: 7772-7782
Chin PT, Bolton DM, Jack G et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 2012; 79: 5-11
Woo HH, Bolton DM, Laborde E et al. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med 2012; 9: 568-575
Lourenco T, Pickard R, Vale L et al. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials. BMJ 2008; 337: a1662
Hoekstra RJ, Van Melick HH, Kok ET, Ruud Bosch JL. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial. BJU Int 2010; 106: 822-826
Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 2007; 52: 1456-1463
Cornu JN, Ahyai S, Bachmann A et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 2015; 67: 1066-1096
Elzayat EA, Elhilali MM. Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol 2007; 52: 1465-1471